Saturday, October 31, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Data updated Oct 31, 2026·New filings added every weekday·Weekly prices as of Oct 2·What changed·
Insider tradingForm 4

SUPERNUS PHARMACEUTICALS, INC. (SUPN) Insider Trading

11 open-market trades reported since Feb 23, 2026: 0 purchases worth $0 and 11 sales worth $9.23M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Padmanabh P. BhattVP0$03$5.39MMar 18, 2026
Jack A. KhattarCEO0$01$1.76MMar 16, 2026
Frederick M. HudsonDirector0$01$272KMar 16, 2026
William Todd HorichSVP0$02$484KMar 10, 2026
Frank MottolaSVP0$01$87KMar 10, 2026
Georges GemayelDirector0$02$1.00MMar 9, 2026
Bethany SensenigDirector0$01$228KFeb 23, 2026

All trades

SUPN insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Mar 18Mar 17Padmanabh P. BhattVPVP▼ SELL10b5-150,00050.30$2.51M−56%Form 4 ↗
Mar 18Mar 16Padmanabh P. BhattVPVP▼ SELL10b5-150,00050.28$2.51M−75%Form 4 ↗
Mar 18Mar 18Padmanabh P. BhattVPVP▼ SELL10b5-17,25049.60$360K−30%Form 4 ↗
Mar 16Mar 13Jack A. KhattarCEOCEO (ind.)▼ SELL10b5-135,00050.38$1.76M−3.5%Form 4 ↗
Mar 16Mar 12Frederick M. HudsonDirectorDirector▼ SELL5,36950.61$272K−8.2%Form 4 ↗
Mar 10Mar 10William Todd HorichSVPSVP▼ SELL4,43955.00$244KAll soldForm 4 ↗
Mar 10Mar 9William Todd HorichSVPSVP▼ SELL4,43854.00$240K−50%Form 4 ↗
Mar 10Mar 9Frank MottolaSVPSVP▼ SELL1,62353.65$87K−8.1%Form 4 ↗
Mar 9Mar 5Georges GemayelDirectorDirector▼ SELL10,00053.71$537K−26%Form 4 ↗
Mar 9Mar 6Georges GemayelDirectorDirector▼ SELL8,78753.00$466K−24%Form 4 ↗
Feb 23Feb 19Bethany SensenigDirectorDirector▼ SELL10b5-14,47551.01$228KAll soldForm 4 ↗
Source: SEC Form 4 filings, retrieved Oct 31, 2026. How we read filings

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.